NA89
NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
07/15/2024
Back to search
Official data from USPTO
EDWARDS
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: US
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
27
Latest update
07/15/2024
Classification
Registered
Trademark type
Word
Nice classes
10
Filing date
12/21/2012
Registration date
02/04/2014
Expiration date
-
Recommended action
Perform a full collision analysis and validate classes before any filing or trademark investment.
Next step
These are the details of the registration process. Even so, constant monitoring is what ensures peace of mind that your main asset remains protected.
Complete case details
Structured fields from the responsible authority and the official record.
Status date
07/15/2024
Last transaction
07/15/2024
Responsible office
United States Patent and Trademark Office
Status code
800
Official register
Principal Register
First use anywhere
03/15/2000
First use in commerce
03/15/2000
Drawing code
4
Owner type
03
Owner location
Irvine, CA, US
Examiner
DALIER,JOHN DAVID
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
E. C. (pessoa física)
Representatives
Avraham Schwartz Edwards Lifesciences Corporation
Technical classification
Nice Classes
Class 10
Vienna Codes
No Vienna codes available.
Goods and services
Class 10
Medical products, namely, cardiovascular devices in the nature of heart valves, annuloplasty rings, cannula, catheters, blood pressure transducers, introducers, probes, blood sampling systems, flushing devices, minimally invasive surgical tools, tissue retractors, and accessories, monitors and disposables for measurement of cardiac output, oxygen saturation, right heart ejection fraction, end diastolic volume, blood chemistry and other parameters of cardiac performance, cardiopulmonary bypass products, surgical clips, occluders, shunts, embolic filters and deflectors, clamps, embolectomy and thrombectomy systems and apparatus, biocompatible and antimicrobial coatings sold as a component of medical products, pericardial patches and other medical apparatus and instruments for the treatment of structural heart disease
Publications
History of USPTO decisions and trademark events.
27 publications found
RNL1
REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
07/15/2024
89AG
REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
07/15/2024
EROP
TEAS RESPONSE TO OFFICE ACTION-POST REG RECEIVED
05/17/2024
PR89
POST REGISTRATION ACTION MAILED - SEC. 8 & 9
05/17/2024
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
05/17/2024
E89R
TEAS SECTION 8 & 9 RECEIVED
02/02/2024
REM2
COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
02/04/2023
NA85
NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
09/13/2019
C15A
REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
09/13/2019
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
09/13/2019
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
08/05/2019
E815
TEAS SECTION 8 & 15 RECEIVED
08/05/2019
R.PR
REGISTERED-PRINCIPAL REGISTER
02/04/2014
PUBO
PUBLISHED FOR OPPOSITION
11/19/2013
NPUB
NOTICE OF PUBLICATION
10/30/2013
PREV
LAW OFFICE PUBLICATION REVIEW COMPLETED
10/16/2013
ALIE
ASSIGNED TO LIE
10/16/2013
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
10/01/2013
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
09/06/2013
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
09/05/2013
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
09/05/2013
CNRT
NON-FINAL ACTION MAILED
03/05/2013
CNRT
NON-FINAL ACTION WRITTEN
03/04/2013
DOCK
ASSIGNED TO EXAMINER
02/25/2013
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
01/09/2013
NWAP
NEW APPLICATION ENTERED
12/25/2012
Continuous trademark protection
Get notified about every new filing that threatens EDWARDS or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.